M7G Methylated Core Genes (METTL1 and WDR4) and Associated RNA Risk Signatures Are Associated with Prognosis and Immune Escape in HCC

Overview

Journal BMC Med Genomics

Publisher Biomed Central

Specialty Genetics

Date 2023 Aug 1

PMID 37528384

Authors

Rui Li

Xincheng Liu

Kaiyuan Deng

Xin Wang

Affiliations

Soon will be listed here.

Abstract

N7 methylguanosine (m7G) has a crucial role the development of hepatocellular carcinoma (HCC). This study aimed to investigate the impact of the m7G methylation core genes (METTL1 and WDR4) and associated RNA risk signatures on HCC. we found m7G methylation core genes (METTL1 and WDR4) were upregulated in four HCC cell lines, and downregulation of METTL1 and WDR4 attenuated HCC cell proliferation, migration, and invasion. Moreover, METTL1 and WDR4 are upregulated in HCC tissues, and that there is a significant positive correlation between them. METTL1 and WDR4 were identified as independent prognostic markers for HCC by employing overall survival (OS), disease-specific survival (DSS), Progression Free Interval survival (PFI), and univariate/multivariate Cox analyses. We identified 1479 coding RNAs (mRNAs) and 232 long non-coding RNAs (lncRNAs) associated with METTL1 / WDR4 by using weighted coexpression network analysis (WGCNA) and co-clustering analysis. The least absolute shrinkage and selection operator (lasso) were used to constructing mRNA and lncRNA risk signatures associated with the METTL1 / WDR4. These risk were independent poor prognostic factors in HCC. Furthermore, we found that METTL1 / WDR4 expression and mRNA / lncRNA risk scores were closely associated with TP53 mutations. Clinicopathological features correlation results showed that METTL1 / WDR4 expression and mRNA / lncRNA risk score were associated with the stage and invasion depth (T) of HCC. To predict the overall survival of HCC individuals, we constructed a nomogram with METTL1/WDR4 expression, mRNA/lncRNA risk score, and clinicopathological features. In addition, we combined single-cell sequencing datasets and immune escape-related checkpoints to construct an immune escape-related protein-protein interaction(PPI) network. In conclusion, M7G methylated core genes (METTL1 and WDR4) and associated RNA risk signatures are associated with prognosis and immune escape in HCC.

Citing Articles

Functions of METTL1/WDR4 and QKI as m7G modification - related enzymes in digestive diseases.

Zhou W, Yi Y, Cao W, Zhong X, Chen L Front Pharmacol. 2025; 15():1491763.

PMID: 39850560 PMC: 11754259. DOI: 10.3389/fphar.2024.1491763.

METTL Family in Healthy and Disease.

He J, Hao F, Song S, Zhang J, Zhou H, Zhang J Mol Biomed. 2024; 5(1):33.

PMID: 39155349 PMC: 11330956. DOI: 10.1186/s43556-024-00194-y.

References

Donisi C, Puzzoni M, Ziranu P, Lai E, Mariani S, Saba G . Immune Checkpoint Inhibitors in the Treatment of HCC. Front Oncol. 2021; 10:601240. PMC: 7874239. DOI: 10.3389/fonc.2020.601240. View

Pinero F, Dirchwolf M, Pessoa M . Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment. Cells. 2020; 9(6). PMC: 7349517. DOI: 10.3390/cells9061370. View

Xu J, Ji L, Liang Y, Wan Z, Zheng W, Song X . CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1. Signal Transduct Target Ther. 2020; 5(1):298. PMC: 7762756. DOI: 10.1038/s41392-020-00375-5. View

Katsara O, Schneider R . mG tRNA modification reveals new secrets in the translational regulation of cancer development. Mol Cell. 2021; 81(16):3243-3245. PMC: 10883294. DOI: 10.1016/j.molcel.2021.07.030. View

Pandolfini L, Barbieri I, Bannister A, Hendrick A, Andrews B, Webster N . METTL1 Promotes let-7 MicroRNA Processing via m7G Methylation. Mol Cell. 2019; 74(6):1278-1290.e9. PMC: 6591002. DOI: 10.1016/j.molcel.2019.03.040. View

Han C, Jiang Y, Wang Z, Wang H . Natural killer cells involved in tumour immune escape of hepatocellular carcinomar. Int Immunopharmacol. 2019; 73:10-16. DOI: 10.1016/j.intimp.2019.04.057. View

Tian F, Cai D . Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma. Gene. 2021; 807:145964. DOI: 10.1016/j.gene.2021.145964. View

Giannelli G, Koudelkova P, Dituri F, Mikulits W . Role of epithelial to mesenchymal transition in hepatocellular carcinoma. J Hepatol. 2016; 65(4):798-808. DOI: 10.1016/j.jhep.2016.05.007. View

Han H, Yang C, Ma J, Zhang S, Zheng S, Ling R . N-methylguanosine tRNA modification promotes esophageal squamous cell carcinoma tumorigenesis via the RPTOR/ULK1/autophagy axis. Nat Commun. 2022; 13(1):1478. PMC: 8933395. DOI: 10.1038/s41467-022-29125-7. View

10.

Xia J, Wu C, Tang Y, Tang J, Zhu D, Zhang F . CircMYH9 increases KPNA2 mRNA stability to promote hepatocellular carcinoma progression in an EIF4A3-dependent manner. Am J Cancer Res. 2022; 12(9):4361-4372. PMC: 9548019. View

11.

Meng Y, Lou X, Yang L, Li D, Hou Y . Role of the autophagy-related marker LC3 expression in hepatocellular carcinoma: a meta-analysis. J Cancer Res Clin Oncol. 2020; 146(5):1103-1113. PMC: 7142043. DOI: 10.1007/s00432-020-03174-1. View

12.

Feng Y, Tang X, Li C, Su Y, Wang X, Li N . ARID1A Is a Prognostic Biomarker and Associated with Immune Infiltrates in Hepatocellular Carcinoma. Can J Gastroenterol Hepatol. 2022; 2022:3163955. PMC: 8752298. DOI: 10.1155/2022/3163955. View

13.

Xie C, Li S, Fang J, Zhu Y, Yang J . Functional long non-coding RNAs in hepatocellular carcinoma. Cancer Lett. 2020; 500:281-291. DOI: 10.1016/j.canlet.2020.10.042. View

14.

Ma J, Han H, Huang Y, Yang C, Zheng S, Cai T . METTL1/WDR4-mediated mG tRNA modifications and mG codon usage promote mRNA translation and lung cancer progression. Mol Ther. 2021; 29(12):3422-3435. PMC: 8636169. DOI: 10.1016/j.ymthe.2021.08.005. View

15.

Cheng W, Gao A, Lin H, Zhang W . Novel roles of METTL1/WDR4 in tumor via mG methylation. Mol Ther Oncolytics. 2022; 26:27-34. PMC: 9217986. DOI: 10.1016/j.omto.2022.05.009. View

16.

Xia P, Zhang H, Xu K, Jiang X, Gao M, Wang G . MYC-targeted WDR4 promotes proliferation, metastasis, and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma. Cell Death Dis. 2021; 12(7):691. PMC: 8270967. DOI: 10.1038/s41419-021-03973-5. View

17.

Xu K, Xia P, Gongye X, Zhang X, Ma S, Chen Z . A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression. Mol Metab. 2022; 63:101540. PMC: 9287641. DOI: 10.1016/j.molmet.2022.101540. View

18.

Wilkerson M, Hayes D . ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010; 26(12):1572-3. PMC: 2881355. DOI: 10.1093/bioinformatics/btq170. View

19.

Long J, Wang A, Bai Y, Lin J, Yang X, Wang D . Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma. EBioMedicine. 2019; 42:363-374. PMC: 6491941. DOI: 10.1016/j.ebiom.2019.03.022. View

20.

Sobolewski C, Abegg D, Berthou F, Dolicka D, Calo N, Sempoux C . S100A11/ANXA2 belongs to a tumour suppressor/oncogene network deregulated early with steatosis and involved in inflammation and hepatocellular carcinoma development. Gut. 2020; 69(10):1841-1854. DOI: 10.1136/gutjnl-2019-319019. View